Combination Therapy With Plasmapheresis, IVIG, and Rituximab Provides Benefit in the Management of Early Antibody Mediated Rejection in Lung Transplant in a Pilot Cohort

Details

Language :

English

ISSN :

00123692 and 19313543

Volume :

144

Issue :

4, Number 4 Supplement 1

Database :

Supplemental Index

Journal :

Chest

Publication Type :

Periodical

Accession number :

ejs38381153

Full Text :

https://doi.org/10.1378/chest.1704606